Latest News
|
19 February 2013
2 Likes 
The patient is male, middle-aged and has just suffered a massive heart attack. For now, he’s sedated, covered by blue cloth and being operated on by a female surgeon, with another attending surgeon
Read More...
Latest News
|
30 January 2013
1 Likes
The US Food and Drug Administration (FDA) has issued a rare multi-agency warning letter to a marketer of a product claiming to give patients protection against the influenza virus.The letter, sent on
Read More...
Latest News
|
4 December 2012
1 Likes
In a potentially landmark ruling, the US 2nd Circuit Court of Appeals has reversed a lower court's finding that a pharmaceutical sales representative was guilty of promoting off-label uses for certain
Read More...
Latest News
|
23 October 2012
0 Likes
The US Food and Drug Administration (FDA) has sent a warning letter to dietary supplement manufactured Advanced Nutritional Technology (AN) Inc. after regulators said an inspection found deficiencies
Read More...
Latest News
|
17 October 2012
0 Likes
Officials with Abbott Laboratories have announced the suspension of a controversial policy that has stoked controversy with critics who claim the company is buying favors from prescribing physicians
Read More...
Latest News
|
16 October 2012
0 Likes
The US Food and Drug Administration (FDA) has taken aim at another of the cosmetic industry's giants over the use of marketing claims reserved for approved pharmaceutical products—its fourth warning
Read More...
Latest News
|
15 October 2012
0 Likes
The US Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) has issued an untitled letter to Genentech over marketing materials used to promote its drug Tarceva
Read More...
Latest News
|
12 October 2012
0 Likes
Pharmaceutical and medical devices industries doing business in Ireland may soon find it more difficult to market their products under new guidance developed by the Irish Medical Council aimed at
Read More...
Latest News
|
3 October 2012
2 Likes
Life sciences manufacturer Abbott has pleaded guilty to charges of unlawfully promoting its anti-seizure drug Depakote (divalproex sodium) and will pay a total of $1.5 billion in fines and be subject
Read More...
Latest News
|
2 October 2012
0 Likes
The US Food and Drug Administration (FDA) is increasingly cracking down on the marketing claims used by some cosmetic companies, firing off at least three warning letters in as many weeks regarding
Read More...